27-07-2025
Minapharm Pharmaceuticals (MIPH.CA) Reports 3 Months Consolidated Results
Source: EGX
Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Currency : EGP
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Profit : 2,347,557
F/S Consolidated Period : From 01/01/2024 To 31/03/2024
Net Comparative Loss : 24,718,253
Audit Status : Reviewed
Source : Minapharm Pharmaceuticals
The Financial Statements in Arabic (30,845 KB) The Financial Statements in English (30,912 KB)
Market HighLights
EGX30
Market Breadth ***
Advancing : Declining 1.22 : 1
shares
Advancing11850%
Declining9741%
Unchanged208%
Total235
T/O (EGP Mn)406224501436175
Volume (Mn)1915944557413
Sector Ranking by Activity
| Sector Name | T/O (EGP Mn) | Mkt % |
| Financial Services & Electronic Payments | 1,331.10 | 32.76 |
| Real Estate and Hotels | 761.36 | 18.74 |
| Industrial, Construction and Materials | 519.97 | 12.80 |
| Food and Beverage | 322.31 | 7.93 |
| Banks | 315.98 | 7.78 |
| Chemicals | 205.05 | 5.05 |
| Healthcare and Pharmaceuticals | 186.12 | 4.58 |
| Energy | 125.88 | 3.10 |
| Other | 88.44 | 2.18 |
| Transportation, Shipping and Logistics | 74.66 | 1.84 |
| Technology, Media and Telecom | 66.56 | 1.64 |
| Consumer Discretionary | 55.88 | 1.38 |
| Education | 9.69 | 0.24 |